FDA warning letter study
An article in the October 2012 issue of Applied Clinical Trials describes a warning letter study that was undertaken by Rajendra Talele of Lambda Therapeutic Research and Dr. Suresh K. Bowalekar of Pharmanet Clinical Services. Although both authors are located in Mumbai, India, their article is…